@sciencefunn: This modified compound is known as JRT, developed by researchers at Delix Therapeutics and the University of California, Davis. By replacing specific atoms in LSD’s structure, they created a molecule that retains therapeutic properties but significantly reduces or eliminates hallucinogenic effects. JRT acts as a serotonin receptor modulator and has shown antidepressant-like and pro-cognitive effects in animal studies, making it a promising candidate for treating conditions like schizophrenia and depression. Another related compound is SPT-348, a prodrug of 2-bromo-LSD (also known as BOL-148). SPT-348 is designed to bypass first-pass metabolism in the liver, enhancing its therapeutic potential. Like JRT, it aims to provide the mental health benefits associated with psychedelics without inducing hallucinations. These developments represent a significant step in creating next-generation psychoplastogens—compounds that promote neural plasticity—offering new avenues for mental health treatments without the side effects commonly associated with traditional psychedelics. Follow us 👉 @sciencefunn for more science and daily facts.🤓  Enjoy the rest of your day.😇

Science Is Fun

Open In TikTok:

Region: SK

Tuesday 13 May 2025 17:08:19 GMT